Fundz

Petros Pharmaceuticals Announces Capital Raise Of $15 Million

PUBLIC · PTPIJul 13, 2023

Round Type

Funding Round

New YorkBiotechnologyHealthcareHealth CareMen's

Investors

Petros Pharmaceuticals

Description

NEW YORK, NY / July 13, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or "the Company"), a pioneer in expanding consumer access to medication through the over the counter (OTC) pathway, today announces a $15 million private placement financing that will support its continued progress towards bringing its erectile dysfunction (ED) drug, STENDRA, to non-prescription OTC status.

Quick answer

Petros Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round, dated July 13, 2023. Investors: Petros Pharmaceuticals. Petros Pharmaceuticals, Inc. is based in New York, United States.

How much did Petros Pharmaceuticals, Inc. raise?
Petros Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round on July 13, 2023.
Who invested in Petros Pharmaceuticals, Inc?
Petros Pharmaceuticals is named as investors in this round.
What does Petros Pharmaceuticals, Inc. do?
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues,..
Where is Petros Pharmaceuticals, Inc. based and how big is it?
Petros Pharmaceuticals, Inc. is based in New York, United States.
Who are the decision-makers at Petros Pharmaceuticals, Inc?
Fundz holds 1 contact at Petros Pharmaceuticals, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Men's around the same time

Companies in the same sectors as Petros Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Zetagen Therapeutics raised an undisclosed amount (Series B) on August 11, 2023.
  • ADARx Pharmaceuticals, Inc. raised $200M (Series C) on August 9, 2023.
  • ADARx Pharmaceuticals, Inc. raised $200M on August 2, 2023.
  • Nuo Therapeutics raised $1M (Seed) on August 1, 2023.
  • Greenbrook TMS raised $3M (Seed) on August 1, 2023.
  • Sanara MedTech raised $3M (Seed) on August 1, 2023.

Who to call at Petros Pharmaceuticals, Inc., and when

A new round usually means Petros Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Petros Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Petros Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Petros Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Petros Pharmaceuticals, Inc.

Location

1185 AVENUE OF THE AMERICAS, SUITE 249

New York, United States

About

Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health, and substance use disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Petros Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsWayne W., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Petros Pharmaceuticals, Inc.'s next move

See what Strategic adds

Petros Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.